Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,330 | -12,673 | -39,119 | -31,965 | -21,951 |
| Depreciation Amortization | 1,498 | 751 | 565 | 398 | 261 |
| Income taxes - deferred | N/A | N/A | -133 | N/A | N/A |
| Accounts receivable | -20 | 1,204 | -3,415 | -1,410 | -1,300 |
| Other Working Capital | 3,274 | 3,291 | -5,996 | -1,688 | -1,496 |
| Other Operating Activity | 2,073 | -540 | 7,961 | 5,014 | 4,593 |
| Operating Cash Flow | $-11,505 | $-7,967 | $-40,137 | $-29,651 | $-19,893 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,421 | -494 | -322 | -228 | -216 |
| Net Acquisitions | N/A | N/A | -6,202 | N/A | N/A |
| Investing Cash Flow | $-2,421 | $-494 | $-6,524 | $-228 | $-216 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11 | N/A | 1,737 | 1,015 | 116 |
| Other Financing Activity | 0 | 0 | -292 | 0 | 0 |
| Financing Cash Flow | $11 | $N/A | $1,445 | $1,015 | $116 |
| Exchange Rate Effect | -42 | 33 | 17 | N/A | 0 |
| Beginning Cash Position | 74,103 | 74,103 | 119,302 | 119,302 | 119,302 |
| End Cash Position | 60,146 | 65,675 | 74,103 | 90,438 | 99,309 |
| Net Cash Flow | $-13,957 | $-8,428 | $-45,199 | $-28,864 | $-19,993 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,505 | -7,967 | -40,137 | -29,651 | -19,893 |
| Capital Expenditure | -2,735 | -607 | -370 | -274 | -233 |
| Free Cash Flow | -14,240 | -8,574 | -40,507 | -29,925 | -20,126 |